The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

vensica.com

Founded Year

2014

Stage

Series B - II | Alive

Total Raised

$21.5M

Last Raised

$3M | 6 mos ago

About Vensica Therapeutics

Vensica is leveraging the known properties of ultrasound (increased tissue permeability and improved uptake of drugs) and is developing a ​drug delivery platform to the urinary bladder. Using the VensiCare device, ultrasound cavitation safely and effectively delivers Botox into the bladder wall in a quick, pain­free, needle­-free procedure in an office setting, and is not expected to have adverse side effects.

Vensica Therapeutics Headquarter Location

6 Hagavish Street

Misgav, 4250706,

Israel

917-963-8694

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vensica Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vensica Therapeutics is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

8,449 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

7,900 items

Vensica Therapeutics Patents

Vensica Therapeutics has filed 2 patents.

The 3 most popular patent topics include:

  • Beta blockers
  • Calcium channel blockers
  • Medical ultrasonography
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/1/2019

Beta blockers, Calcium channel blockers, Medical ultrasonography, Ultrasound, Potassium channel blockers

Application

Application Date

4/1/2019

Grant Date

Title

Related Topics

Beta blockers, Calcium channel blockers, Medical ultrasonography, Ultrasound, Potassium channel blockers

Status

Application

Latest Vensica Therapeutics News

Merz Therapeutics Takes a Bet on Vensica Therapeutics

Feb 13, 2022

Vensica Therapeutics is a urology therapeutics and clinical stage biopharmaceutical company. Vensica Therapeutics has closed a $19 million investment round. Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to $3 million, bringing the total round to up to $19 million. The […]

  • When was Vensica Therapeutics founded?

    Vensica Therapeutics was founded in 2014.

  • Where is Vensica Therapeutics's headquarters?

    Vensica Therapeutics's headquarters is located at 6 Hagavish Street, Misgav.

  • What is Vensica Therapeutics's latest funding round?

    Vensica Therapeutics's latest funding round is Series B - II.

  • How much did Vensica Therapeutics raise?

    Vensica Therapeutics raised a total of $21.5M.

  • Who are the investors of Vensica Therapeutics?

    Investors of Vensica Therapeutics include Merz Therapeutics, The Trendlines Group, Laborie Medical Technologies, Israel Biotech Fund, Agriline and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.